Cargando…
Tofacitinib for the Treatment of Steroid-Induced Rosacea
PURPOSE: Conventional treatment suffers from a dilemma of poor efficacy. The clinical use of Janus kinase (JAK) inhibitors in the treatment of steroid-induced rosacea has rarely been explored. PATIENTS AND METHODS: We present a case of steroid-induced rosacea successfully treated with JAK inhibitor...
Autores principales: | Li, Tianhao, Wang, Henghong, Wang, Caiying, Hao, Pingsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701777/ https://www.ncbi.nlm.nih.gov/pubmed/36452437 http://dx.doi.org/10.2147/CCID.S392280 |
Ejemplares similares
-
Tofacitinib for Prurigo Nodularis: A Case Report
por: Peng, Changlan, et al.
Publicado: (2022) -
Tofacitinib for the Treatment of Psoriasiform Dermatitis Caused by IL-17 Inhibitors: A Case Report
por: Luo, Nan, et al.
Publicado: (2023) -
Treatment of granulomatous rosacea with adalimumab
por: Saal, Ryan C., et al.
Publicado: (2023) -
Rosacea fulminans: unusual clinical presentation of rosacea
por: Coutinho, Jessica Castiel, et al.
Publicado: (2016) -
Treatment of Resistant Alopecia areata with Tofacitinib
por: Avhad, Ganesh
Publicado: (2022)